small molecule

AEROSPAN HFA

FLUNISOLIDE

Loss of exclusivityloss of exclusivity
CompanyPHARMOBEDIENT CONSULTING LLC

Drug detail

Brand nameAEROSPAN HFA
Active ingredientFLUNISOLIDE
Strength0.078MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalJanuary 2006
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AEROSPAN HFA patent cliff — loss of exclusivity — | CliffBio